Dennis M. Greene

Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer.

MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ.

Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ.

Dick Clark Productions, Inc. produces television shows. The firm delivers programs through broadcast networks, cable networks, distributors and advertisers. The company was founded in 1957 and is headquartered in Santa Monica, CA.

Pro-Football, Inc. owns and operates a professional American football team. The company manages the Washington Redskins which is part of the Eastern Division of the National Football Conference of the National Football League (NFL). The team was founded in July 1932 and is headquartered in Ashburn, VA.

Astra Zeneca Oy engages in the development and manufacture of biopharmaceutical products. It specializes in clinical drug research in oncology, diabetes, and cardiovascular diseases. The company was founded on March 19, 1965 and is headquartered in Espoo, Finland.